Urinary Calculi
29
6
6
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.4%
1 terminated out of 29 trials
90.9%
+4.4% vs benchmark
17%
5 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (29)
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
Ultrasound to Facilitate Stone Passage
Break Wave(TM) Extracorporeal Lithotripter First-in-Human Study
Flexiva Pulse Registry
WeChat-Based Digital Therapy to Improve Fluid Intake in Kidney Stone Patients: Study Protocol
A Prospective Multicenter Randomized Controlled Trial of Flexible And Navigable Suction Ureteral Access Sheath Combined With Needle Perc for the Treatment of Partial Staghorn Renal Calculi
SP TLF Versus Ho:YAG Laser
Tubeless Percutaneous Nephrolithotomy Without Reverse Insertion of a Ureteral Catheter
Endoscopic Combined Intrarenal Surgery vs. Percutaneous Nephrolithotomy for Treatment of Staghorn Calculi
Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis
Prospective Randomized Controlled Trial for Pain Relief After Office Ureteral Stent Removal
ESWL for Distal Ureteric Stone: Supine Versus Prone
Shuotongo Ureteroscopy for Upper Urinary Tract Stones
Evaluation of Kidney Function by Multi-modal Magnetic Resonance Imaging and Spectroscopy
Effect of Furosemide on ESWL Outcomes for Renal and Ureteral Calculi
The Effect of the COVID-19 on Patient Preferences and Decision Making for Obstructive Urinary Stone Interventions
Treatment of Upper Urinary Tract Stones With a Diameter≤2cm by Intelligent Pressure-controlled Flexible Ureteroscope
Computed Tomography Evaluation of Urinary Stones Densities Compared to in Vitro Analysis of Its Chemical Composition
Analysis the Relationship Between the Abdomen CT and Outcomes in Acute Urinary Stone Patients
Use of Alfuzosin in Stone Treatment With ESWL